πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 52 of 200 Β· A–Z by INN

  1. denosumab-nxxp

    BILPREVDA

    INJECTION FDA: approved

  2. denosumab-qbde

    ENOBY

    INJECTION FDA: approved

  3. deoxycholic acid

    DEOXYCHOLIC ACID

    SUBCUTANEOUS FDA: approved

  4. depemokimab

    EXDENSUR

    EMA: approved

    R03DX12
  5. depemokimab-ulaa

    EXDENSUR

    FDA: approved

  6. depreotide

    NEOSPECT

    EMA: withdrawn

    V09IA05
  7. deprivation

    NMPA: clinical trials

  8. derivative

    NMPA: clinical trials

  9. deserpidine

    ORETICYL 50

    ORAL FDA: approved

  10. desferrioxamine

    DBL DESFERRIOXAMINE MESILATE Pfizer Australia Pty Ltd

    TGA: approved

  11. desflurane

    SUPRANE

    INHALATION FDA: approved

  12. desipramine hydrochloride

    DESIPRAMINE HYDROCHLORIDE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  13. desirudin

    REVASC

    EMA: withdrawn

    B01AE01
  14. desirudin recombinant

    IPRIVASK

    SUBCUTANEOUS FDA: approved

  15. deslanoside

    CEDILANID-D

    INJECTION FDA: approved

  16. desloratadine

    DESLORATADINE KRKA Teva Pharma GmbH

    ORAL FDA: approved Β· EMA: approved

    R01BA52
  17. desmopressin

    MINIRIN Ferring Pharmaceuticals

    TGA: approved

  18. desmopressin acetate

    MINIRIN Regeneron Ireland Designated Activity Company (DAC)

    ORAL FDA: approved

  19. desogestrel

    KIMIDESS Teva Pharma GmbH

    ORAL-21 FDA: approved

  20. desonide

    DESOWEN

    TOPICAL FDA: approved

  21. desoximetasone

    TOPICORT

    TOPICAL FDA: approved

  22. desoxycorticosterone acetate

    PERCORTEN

    IMPLANTATION FDA: approved

  23. desoxycorticosterone pivalate

    PERCORTEN

    INJECTION FDA: approved

  24. desvenlafaxine

    APO-DESVENLAFAXINE MR Pfizer Australia Pty Ltd

    ORAL FDA: approved Β· EMA: application withdrawn Β· TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources